◆ What is National Health Information (Healthcare Big Data) ?
The Health Insurance Review & Assessment Service (HIRA) provides vast amounts of healthcare big data, including medical treatment information, pharmaceutical information, and medical resource information, to information seekers in both the public and private sectors through the HIRA system. National Health Information (NHI) is healthcare big data collected in real time through various channels, including nationwide medical records, medical institutions, pharmaceutical companies, and related organizations. This data is analyzed and refined.
◆ What data will be opened?
The Health Insurance Review & Assessment Service Open Data Information Table displays the data provider, open data, total number of open cases, and provision method information. Data provider | open data | Number of data | How it's provided |
|---|
Health Insurance Review & Assessment Service | - Provides medical information based on medical resources and claims data from 87,000 medical institutions nationwide, covering 50 million people. - Medical treatment information, pharmaceutical information, and treatment material information | 525.8 billion cases | file data, Open API |
< Provided by the Health Insurance Review & Assessment Service's Healthcare Big Data Open System >
◆ How can it be used?
The pharmaceutical industry, medical device industry, medical institutions, universities, and research institutes will be able to utilize healthcare big data, which is highly popular with the public, and systematically analyze it to create big data value, such as promoting national health, strengthening the competitiveness of the healthcare industry, stimulating research, and generating revenue for the industry.
The pharmaceutical and medical device industries are expected to utilize open healthcare big data to build a health information database, which is essential for producing smart healthcare devices, and to provide users with self-management and prevention information through big data analysis, while also laying the foundation for producing high value-added medical devices.
It is expected that the expansion of data opening for private sector use, such as pharmaceuticals and hospital care, will support the discovery of new businesses and startups in the healthcare sector, and that it will be possible to train healthcare big data analysis experts.